Design, synthesis and biological evaluation of novel (E)-α-benzylsulfonyl chalcone derivatives as potential BRAF inhibitors
QS Li, CY Li, X Lu, H Zhang, HL Zhu
Index: Li, Qing-Shan; Li, Cui-Yun; Lu, Xiang; Zhang, Hui; Zhu, Hai-Liang European Journal of Medicinal Chemistry, 2012 , vol. 50, p. 288 - 295
Full Text: HTML
Citation Number: 18
Abstract
Activating mutations in the BRAF serine/threonine kinase are found in more than 70% of human melanomas,> 90% of which are BRAFV600E. It provides new therapeutic opportunities in malignant melanoma. In silico and in vitro screening of our compound collection has identified Hit 2 as BRAFV600E inhibitor. Based on its structure, a series of novel (E)-α-benzylsulfonyl chalcone derivatives (13–40) were designed and synthesized. ...
Related Articles:
[Loghmani-Khouzani, Hossein; Poorheravi, Mohammad R.; Sadeghi, Majid M.M.; Caggiano, Lorenzo; Jackson, Richard F.W. Tetrahedron, 2008 , vol. 64, # 30-31 p. 7419 - 7425]
[Bordwell; Zhang, Xian-Man; Alnajjar, Mikhail S. Journal of the American Chemical Society, 1992 , vol. 114, # 20 p. 7623 - 7629]
[Kianmehr, Ebrahim; Mirza Agha, Mansoureh; Estiri, Hamid Monatshefte fur Chemie, 2010 , vol. 141, # 4 p. 409 - 411]
[Hengchang, Chen; Zhenzhong, Liu; Wei, Liu Synthetic Communications, 1990 , vol. 20, # 21 p. 3313 - 3316]
[Ranu, Brindaban C.; Mandal, Tanmay; Banerjee, Subhash; Dey, Suvendu S. Australian Journal of Chemistry, 2007 , vol. 60, # 4 p. 278 - 283]